This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Sanofi recalls all lots of Allerject (0.15 mg/0.15 mL and 0.3 mg/0.3 mL strengths of epinephrine auto-injectors)
- Starting date:
- October 28, 2015
- Posting date:
- October 28, 2015
- Type of communication:
- Source of recall:
- Health Canada
- Product Safety
- General Public
- Identification number:
- Products affected
- What you should do
- Who is affected
- Report health or safety concerns
- Media enquiries
- Public enquiries
- What Health Canada is doing
Sanofi-aventis Canada Inc., in consultation with Health Canada, is recalling all lots of Allerject (0.15 mg/0.15mL and 0.3 mg/0.3 mL strength epinephrine auto-injectors) from the Canadian market. A similar recall is taking place in the United States, where it’s sold as Auvi-Q.
This recall is due to issues that may potentially affect the delivery of the required amount of the drug, epinephrine. Allerject is used as an emergency treatment by patients who are at risk and/or have a history of serious allergic reactions (anaphylaxis).
In light of the need to manage supply associated with this recall, we are asking customers and pharmacists to limit the replacement of Allerject to one unit or the appropriate number of units as instructed by your healthcare professional until full alternative stock is available.
- Allerject Pre-filled Autoinjector (DIN02382059 – 0.15mg/0.15mL epinephrine).
- Allerject Pre-filled Autoinjector (DIN02382067 – 0.3mg/0.3mL epinephrine).
What you should do
- Contact your pharmacy to arrange returning your Allerject device and to obtain a replacement epinephrine auto-injector with the same dose.
- Consult your pharmacist to ensure you understand how to properly use the replacement auto-injector.
- In the event a life-threatening allergic reaction (anaphylaxis) occurs before you can obtain a replacement auto injector, use your Allerject device as directed by your healthcare provider, and then seek emergency medical attention.
- Speak with your healthcare professional if you are concerned about your health or your child’s health.
- Report any adverse events to Health Canada.
Who is affected
Adults and children who use Allerject (0.15 mg / 0.15 mL and 0.3 mg/0.3 mL auto-injector).
Report health or safety concerns
How to report side effects to health products to Health Canada:
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
What Health Canada is doing
Health Canada is monitoring the company’s recall and will inform Canadians if any new information arises.
Select thumbnail to enlarge - opens in a new window